Tag Archives: Medtronic

Medtronic’s Hybrid Closed Loop system pivotal trial results published in the Journal of the American Medical Association

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the Journal of the American Medical Association (JAMA). The data presented the safety of the system … Read the full press release

Medtronic announces the appointment of Mark Ploof as SVP, Global Operations and Business Services

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016.  He will serve on the company’s Executive Committee and be responsible for leading … Read the full press release

Medtronic received Ministry of Health, Labor and Welfare approval for its Reveal LINQ Insertable Cardiac Monitor System in Japan

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke  DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac … Read the full press release

Medtronic’s IN.PACT Admiral drug-coated balloon treatment for in-stent restenosis receives FDA approval

IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment for in-stent … Read the full press release

Medtronic plc SureTune2(TM) software receives CE Mark

New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data DUBLIN, 10-Aug-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which … Read the full press release

Diabetes Management: Medtronic announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions

CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016 DUBLIN and NEW ORLEANS, 10-Jun-2016 — /EuropaWire/ — Delivering on its vision to transform care for the millions currently living with … Read the full press release

Medtronic presents FIRE AND ICE clinical trial findings at a late-breaking session at CARDIOSTIM-EHRA EUROPACE 2016

Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes DUBLIN AND NICE, FRANCE, 10-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of theFIRE AND ICE clinical trial that demonstrate significantly fewer repeat … Read the full press release

Medtronic presents results of new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM / EHRA EUROPACE 2016

Places ICD Leads Under Rib Cage, Outside Heart and Veins DUBLIN and NICE, FRANCE, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM … Read the full press release

Medtronic / University of Texas: First patient enrolled in a clinical study for the minimally invasive repair of descending thoracic aortic aneurysms (TAA)

Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at Houston DUBLIN and HOUSTON, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at … Read the full press release

Lung cancer: Medtronic announced European enrollment in the NAVIGATE clinical trial

NAVIGATE Study Assesses Impact of Minimally Invasive Technology to Aid in Early Diagnosis and Treatment of Lung Cancer DUBLIN, 14-Mar-2016 — /EuropaWire/ — Committed to technologies that assist in the goal of reducing lung cancer morbidity worldwide, Medtronic (NYSE: MDT) today … Read the full press release

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release

Medtronic announced the availability of new CareLink® iPro report called Pattern Snapshot for iPro2 Professional CGM system

Simplified Report Uses New Algorithms to Streamline Diabetes Data Interpretation for the Health Care Professional DUBLIN, 1-12-2015 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the availability of a new CareLink® iPro report called Pattern Snapshot … Read the full press release

Medtronic: First implants of the TYRX(TM) Absorbable Antibacterial Envelope with Medtronic Deep Brain Stimulation (DBS) systems

DUBLIN, 9-10-2015 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced the first implants of the TYRX(TM) Absorbable Antibacterial Envelope with Medtronic Deep Brain Stimulation (DBS) systems. The implants were conducted by Francisco Ponce, M.D., director, Barrow Center for Neuromodulation, at the … Read the full press release

Medtronic to present notable clinical studies at Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Francisco, Oct 11-15, 2015

Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled Stent DUBLIN, 8-10-2015 — /EuropaWire/ — Medtronic plc (NYSE: … Read the full press release

Medtronic demonstrates the durability of the Valiant® Thoracic Stent Graft System after five-year data in VALOR II Study

Valor II U.S. Study Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms DUBLIN and Newport, R.I., 8-10-2015 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced favorable five-year data in the VALOR II Study, demonstrating the durability of the Valiant® … Read the full press release

Sanofi and Medtronic partner to improve patient experience and outcomes for people with diabetes around the world

Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to enter into a … Read the full press release